Funding Details
- Awarder
- Inbox
- Date Award
- March 01, 2023
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$147,000,000
Company Info
- Traction
- Four programs currently in active Phase 2 clinical trials with readouts expected in 2025.
- Company Description
- Noema Pharma is a biotech company that develops therapies to address disabling symptoms in conditions of the brain and nervous system.
- Market
- Central Nervous System Disorders
- Location
-
Basel,
Switzerland
- Coinvestors
- EQT Life Sciences, Forbion, Jeito Capital, Sofinnova Partners, Gilde Healthcare, Polaris Partners, Invus, UPMC Enterprises
Links